INTRODUCTION
Infl ammatory bowel diseases (IBD), comprising Crohn ' s disease (CD) and ulcerative colitis (UC), are complex polygenic disorders in which genotypic profi les may infl uence disease characteristics. Consequently, disease phenotype may vary among racial and ethnic groups secondary to variations in IBD genetic susceptibility loci. Th e National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)-IBD Genetics Consortium has characterized the IBD phenotype in African Americans and Hispanics (1) , the two major minority populations in the United States. Knowledge of ethnic variations in the clinical presentation of IBD may facilitate the approach to diagnosis and management of IBD in these populations (2, 3) .
One of the earliest immigrant populations to North America were the French, and they played a signifi cant role in its early development through widespread colonization (4) . In particular, the current French-Canadian population of 6 million people in Quebec descended from ~ 8,500 French colonists who arrived between 1608 and 1759 (5) , coming mainly from Atlantic seaports and Paris (6) . Th us, the French-Canadian population evolved from a small sample of the French population, and founder eff ects and distant consanguinity in subsequent generations have created a unique distribution pattern of several diseases (7) .
Th e NIDDK-IBD repository is a North America wide eff ort to clinically characterize IBD. It provides an excellent opportunity to clinically characterize the IBD phenotype in the FrenchCanadian population, genetically more homogeneous than either the Hispanic or the African-American populations that our group had studied earlier (1) . Th e manifestations of IBD in this population, having immigrated from France 400 years ago and evolved over generations exposed to the North American environment, may have implications for IBD genotype -phenotype correlations in more recent immigrant populations. Given the founder eff ects in other genetically transmitted conditions prevalent among French Canadians, including some with a polygenic basis, we hypothesize the presence of a distinct IBD phenotype in this population.
METHODS

Subjects
Patients with IBD were recruited from multiple centers across the United States and Canada and registered in the Infl ammatory Bowel Disease Genetics Consortium (IBDGC). Th e IBDGC was commissioned by the NIDDK for pooling of genetic specimens and clinical phenotype data for IBD genetic studies.
A retrospective analysis of data was conducted to assess for any diff erences in the IBD phenotype between the French-Canadian patients and other Caucasians in the repository. Th e six genetic research centers involved in our consortium were the Universit é de Montr é al, the Cedars-Sinai Hospital in Los Angeles, the Johns Hopkins University, the University of Chicago, the University of Pittsburgh, and the University of Toronto. Th e Broad Institute recruited patients from the QIGC (Quebec IBD Genetics Consortium), which consists of eight adult hospital centers and one pediatric center spanning the province of Quebec. Th e patients were recruited at each of these centers between 27 January 1997 and 20 December 2005. Recruitment of patients was based solely on the diagnosis of IBD. Diagnosis of CD, UC, and indeterminate colitis was confi rmed by gastroenterologists through the assessment of clinical, endoscopic, radiological, and histopathological records using standardized defi nitions as specifi ed in the NIDDK-IBD Genetics Consortium operating manual. Th is operating manual has been proven to generate reliable and valid phenotypic assessments (8) . We accessed the NIDDK-IBDGC database for demographic data, clinical phenotype data, including age at diagnosis, disease location, and extent, disease behavior (for CD), tobacco use, family history, extraintestinal manifestations (EIMs), and surgical history. A positive family history of IBD, obtained by patient self-report, was the presence of either CD or UC in fi rst-or second-degree relatives, including grandparents, half-siblings, and avuncular relatives. Patients were designated as smokers if they had smoked at least one cigarette per day for at least 3 months before the diagnosis of IBD, and as ex-smokers if they had consumed tobacco before that point in time.
Designation of race and ethnicity
Th e NIDDK database contains the following racial designations: Caucasian, African American, American Indian / Alaskan Native, Asian, or Other by self-report. Our population of interest was the French-Canadian patients from the Quebec centers. Designation of French-Canadian ethnicity was based on selfreport. We were able to contact 168 patients to inquire whether at least three out of four of their grandparents were of FrenchCanadian ancestry. An excellent correlation has been found between self-identifi ed race -ethnicity and genetic cluster categories (9) . However, we used these more stringent criteria in a sensitivity analysis to validate that there were no signifi cant phenotypic diff erences compared with self-reported ethnicity. We felt that this would consolidate phenotypic characterization and enable future assessment of genetic variations specifi c to the French-Canadian population.
Medical, radiological, endoscopic, operative, and pathological records were reviewed for all areas of the gastrointestinal tract macroscopically involved throughout the disease course. For CD, the anatomical location of disease was designated as esophagogastroduodenal, jejunal, ileal, colonic, and perianal. If information regarding the involvement of a certain portion of the gastrointestinal tract was missing, disease status was designated as " unknown. " History of perianal abscess and / or fi stula, anal canal ulcer or stenosis, and chronic edematous skin tags were designated as perianal disease, whereas hemorrhoids or fi ssures were not. We used the Vienna classifi cation system in our protocol as a framework for disease site designation and disease behavior, with adjustments that rendered it consistent with the Montreal classifi cation system. We thus classifi ed patients into the following three groups on the basis of disease location: (i) ileal: macroscopic disease solely of the ileum; (ii) colon-only: involvement limited to the colon or the rectum; and (iii) ileocolonic: both ileal and colonic involvement without proximal small bowel infl ammation. According to the Montreal classifi cation, we categorized the presence of upper gastrointestinal and perianal involvement as an adjunct or an independent designation. Disease location designation was based on the maximal extent of involvement at any point during the course of the disease. Th e Montreal classifi cation system for CD has been found to be accurate and reproducible on testing with clinical databases (10 -12) .
Patients with UC were classifi ed on the basis of colonoscopy, barium enema, or colectomy pathology reports as follows: (i) proctitis: involvement limited to the rectum without crossing the rectosigmoid junction; (ii) left -sided colitis: infl ammation distal to the splenic fl exure; and (iii) extensive colitis: infl ammation proximal to the splenic fl exure.
Extraintestinal manifestations
EIMs of IBD were defi ned on the basis of objective diagnostic criteria in the NIDDK-IBDGC phenotyping and operating manual (13, 14) . In an earlier validation of this phenotyping manual, we have certifi ed the accuracy of the manual criteria for the following EIMs: sacroiliitis, ankylosing spondylitis, uveitis, erythema nodosum,pyoderma gangrenosum, primary sclerosing cholangitis, and arthritis (8) .
Clinical disease behavior
CD behavior was reported as one of three categories based on the Vienna classifi cation. Th ese included (i) infl ammatory: infl ammation with no stricturing or fi stulizing complications during the course of the disease; (ii) stricturing: constant luminal narrowing shown by radiological, endoscopic, or surgical / pathological procedures, along with prestenotic dilatation or obstructive signs / symptoms without fi stulizing disease at any time during the disease course; and (iii) fi stulizing: intraabdominal fi stulas, bowel perforation, infl ammatory masses, and / or abscesses at any time during the disease course. Secondary post-operative intra-abdominal complications were excluded, as were perianal and rectovaginal fi stulae. Th e most severe form of disease behavior at any time point in the disease course was recorded in the database. If both fi stulizing and stricturing disease were present, the patient ' s disease behavior was classifi ed as fi stulizing. As the risk of developing stricturing or fi stulizing phenotype increases with disease duration, we performed a sensitivity analysis of disease behavior for a subgroup of patients diagnosed at least 5 years earlier.
Surgical history
Medical records were checked for surgical procedures that were performed to treat CD and its complications, namely (i) bowel resection or stricturoplasty; (ii) diversions performed before defi nitive bowel resection or to enable the healing of perianal disease; (iii) surgery for abdominal fi stula / abscess; and (iv) surgery for perianal fi stula comprising the placement of a Seton, fi stulotomy, or intestinal diversion to allow for healing of perianal disease. Data on bowel resection for UC were documented as follows: (i) dysplasia or malignancy; (ii) chronic continuous disease; and (iii) acute fulminant disease, defi ned as the onset of severe colitis within a period of 2-weeks in a patient with hitherto undiagnosed or indolent colitis. We have verifi ed the accuracy of these criteria for surgery in our study validating the NIDDK-IBDGC operating manual (8) .
NOD2 single nucleotide polymorphism (SNP) analysis
Th e genotyping of the three key nucleotide-binding oligomerization domain containing 2 (NOD2) of variants (R675W, G881R, 3020insC) among the French-Canadian patients was performed on serum samples using primer extension chemistry and mass spectrometric analysis (iPlex Assay, Sequenom, San Diego, CA) on the Sequenom MassArray at the Montr é al Heart Institute and the Universit é de Montr é al.
Statistical analysis
Th e categorical characteristics of French-Canadian patients were compared with those of other Caucasians using 2 -analysis or Fisher ' s exact test of proportions. Multiple logistic regression models were developed to isolate the independent eff ect of French-Canadian ethnicity on the relative odds of colonic, fi stulizing, and stricturing disease, adjusting for age at study entry, age at diagnosis, gender, tobacco use, and disease duration. Th e NOD2 data were analyzed using 2 -analysis, to determine whether any correlations between NOD2 single nucleotide polymorphisms (SNPs) with either disease behavior or location existed within the French-Canadian population.
Ethical considerations
Th e Institutional Review Boards at all Quebec Infl ammatory Bowel Disease Genetic Consortium centers, the Universit é de Montr é al, the Cedars-Sinai Hospital, the Johns Hopkins University, the University of Chicago, the University of Pittsburgh, the University of Toronto, and the University of Puerto Rico Medical Sciences Campus approved the data collection protocols for their respective sites.
INFLAMMATORY BOWEL DISEASE
Bhat et al.
RESULTS
A total of 1,489 eligible patients with IBD (1,287 Caucasians and 202 French Canadians) were included in this study ( Table 1 ). In our primary analysis, French-Canadian ethnicity was determined by self-report ( n = 202). In a subsequent sensitivity analysis, French-Canadian ethnicity was defi ned by stricter criteria requiring at least three out of four grandparents of this ethnicity. Th is stricter defi nition made 148 subjects eligible for this analysis. Th e characteristics of French Canadians and other Caucasians are shown in Table 1 . Th ere were no statistically signifi cant diff erences in age, age at diagnosis, gender, family history, smoking history, or history of appendectomy between French Canadians and other Caucasians for either CD or UC. However, in the sensitivity analysis, there was a signifi cantly higher number of former smokers among the French-Canadian UC patients (35 vs. 20 % , P = 0.03) when the stricter criterion for ethnicity was used ( Table 2 ) . Th e percentage of current smokers was also higher among French Canadians with CD compared with that of other Caucasians (40 vs. 25 % , P = 0.006).
Family history
A family history of IBD was reported in 21 % of all subjects, with no racial or disease subtype diff erences noted.
CD Phenotype
Th e breakdown of CD anatomical location and behavioral pattern for all subjects (French Canadians and other Caucasians) is given in Table 3 . Th ere was a greater prevalence of colorectal involvement among French Canadians when compared with other Caucasians (79 vs. 66 % , P = 0.006). However, aft er adjustment for age, age at diagnosis, gender, and smoking, IBD, infl ammatory bowel disease. * P < 0.05, ** P < 0.01. 
UC phenotype
Th e anatomical distribution of UC was similar between the French-Canadian and Caucasian patients ( Table 4 ) . Th e overall prevalence of colonic dysplasia was 3 % among all UC patients, with no signifi cant diff erence between the two groups, namely French Canadians (0 % ) and other Caucasians (3 % ).
Surgical history
French Canadians had surgical intervention for CD-related complications at a rate not diff erent from other Caucasians (58 vs. 55 % , P = 0.489), and remained similar aft er adjustment for age, age at diagnosis, gender, smoking, and family history. In addition, there were no diff erences between the two groups when looking in particular at the various types of surgery for CD, namely bowel resection, bowel diversion, surgery for abdominal penetrating disease, and surgery for perianal disease ( Table 2 ). Th ere was no signifi cant diff erence between French Canadians and other Caucasians with respect to the rates of colectomy for chronic refractory UC.
EIMs
Analysis of the data for EIMs revealed no statistically signifi cant diff erences between French Canadians and other Caucasians when considering self-report as the determinant of French-Canadian ethnicity ( Table 5 ). However, when the analysis was performed using the strict criteria for FrenchCanadian ethnicity, sacroiliitis was found to be more prevalent among French Canadians than in other Caucasians (4 vs. 2 % , P = 0.045). Th ere were no statistically signifi cant ethnic diff erences in the prevalence of pyoderma gangrenosum, erythema nodosum, uveitis, ankylosing spondylitis, and primary sclerosing cholangitis.
these ethnic diff erences were no longer statistically signifi cant (odds ratio (OR): 1.74; 95 % confi dence interval (95 % CI): 0.80 -3.80). Th ere was no diff erence between the two groups for best-fi t disease site. Disease behavior analysis revealed that French Canadians had a twofold lower prevalence of stricturing disease (11 vs. 21 % , P = 0.005). Aft er adjustment for age, age at diagnosis, gender, smoking, and disease duration, the OR for having stricturing disease was 0.45 (95 % CI: 0.24 -0.85) for French Canadians compared with other Caucasians. When using the stringent defi nition of ethnicity, there was a tendency (5) 6 (5) 2 (2) For abdominal fi stulizing disease 98 (15) 13 (10) 9 (10) For perianal disease 97 (15) 19 (14) 14 (15) CD, Crohn's disease; NIDDK-IBDGC, National Institute of Diabetes and Digestive and Kidney Diseases-Infl ammatory Bowel Disease Genetics Consortium. * P < 0.05, ** P < 0.01. P values were calculated on the basis of comparisons between the French-Canadian patients (self-identifi ed or strictly defi ned) and the Caucasian control population. 
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NOD2 SNP analysis in French Canadians
We obtained serum samples from 103 out of 202 FrenchCanadian subjects. At least one of the three NOD2 SNPs (R675W, G881R, and 3020insC) was present in 43.2 % of CD patients and 20.3 % of UC patients in the French-Canadian population. Among French Canadians, the prevalence of the 3020insC SNP was signifi cantly greater in individuals with small bowel disease compared with those without small bowel involvement (75 vs. 0 % , P = 0.006) ( Table 6 ). Th ere was no correlation of the NOD2 variants with either stricturing or fi stulizing CD behavior.
DISCUSSION
Our results support the concept that phenotypic characteristics of IBD may vary by ethnicity (1, 15) . Th e distinct behavior of CD in French Canadians is the most striking fi nding, with reduced frequency in stricturing disease and a tendency toward fi stulizing disease behavior. In addition, there seems to be a heightened eff ect of smoking on the onset of IBD in this population. Th e French-Canadian population is a relatively more homogeneous ethnic group when compared with the Hispanics and African Americans of North America. Th e latter two are a more heterogeneous mixture of sub-populations, whereas the current French-Canadian population has its roots in a cluster of Atlantic seaports in France. Th is population with founder eff ects has served as an excellent point of reference for research into genetically transmitted conditions (5, 6) , and it has proven to be so in IBD as well. Defi ning ethnicity for research remains a challenge, given the growing admixture of cultures. Despite this phenomenon, in 2002, Tang et al. (9) reported that self-identifi ed race -ethnicity was suffi cient to categorize individuals into ethnic groups. We found that the same held for our study population; when the analysis was performed for the self-identifi ed French Canadians as a whole, similar results were derived for the French Canadians defi ned by strict criteria.
Th e tendency toward fi stulizing disease among French Canadians may be caused by a genetic predisposition to a more severe CD. Interestingly enough, the higher prevalence of fi stulizing disease did not translate into an increased need for surgical intervention. Th is may have been partly off set by the lesser degree of stricturing disease among French Canadians. Th e tendency toward fi stulizing disease among French Canadians could encourage clinicians to adopt a more anticipatory therapeutic approach upon initial diagnosis, or at the fi rst hint of a more rapidly progressing clinical course. Th ere are several earlier phenotypic studies that have attempted to characterize various ethnic populations on the basis of clinical characteristics of IBD, including disease location, behavior, EIMS, and disease modifi ers (16, 17) . Th ese studies confi rm that IBD phenotype varies among ethnicities.
Th e genotypic basis of CD behavior and location is gradually being unraveled, with the discovery of 11 confi rmed disease loci within the last decade (18) and signifi cant evidence for 21 additional loci more recently (19) . SNPs of NOD2, such as R675W, G881R, and 3020insC, have been associated with CD, with homozygous, or compound heterozygous patients having a 10 -40 times higher relative risk of developing CD than the general population (20) . Th e 43.2 % prevalence of NOD2 variants among French Canadians is congruent with the stated prevalence of 35 -45 % among populations of European ancestry (21) . NOD2 prevalence has been examined earlier within the Quebec population. Vermeire et al. (22) found that 45 % of Quebec IBD patients carried NOD2 variants, and that ileal disease correlated signifi cantly with the presence of NOD2 variants. However, only 58 % of the studied subjects were French Canadians. A recent genome-wide association study of the French-Canadian population identifi ed a number of disease loci that increase the risk of CD (23) .
Several studies in the literature have reported the association of NOD2 variants with stricturing and fi stulizing CD behavior, small bowel involvement, and earlier age at onset (24, 25) . However, such a correlation could not be established in our French-Canadian population, which runs counter to the strong associations found among the other Caucasian groups (26, 27) . Th is lack of association could be on account of type II error. However, the 3020insC SNP did correlate with small bowel involvement in French Canadians with CD.
Smoking has been described in the literature as a moderating factor in the etiopathogenesis of CD, with current smokers having an increased risk of developing CD in a meta-analysis by Calkins (pooled OR: 2.0, CI: 1.65 -2.47) (28) , and more recently in a meta-analysis by Mahid et (29) . We found this association to be stronger among French Canadians than in the other Caucasians in the strict criteria analysis. French Canadians also had a greater propensity to develop UC upon cessation of smoking than did other (2) 1 (1) Primary sclerosing cholangitis 25 (2) 2 (1) IBD, infl ammatory bowel disease. * P < 0.05.
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IBD Phenotype in French-Canadians stricturing disease and a tendency toward fi stulizing disease in the French-Canadian CD population. Th e accentuated response to smoking status in IBD among French Canadians (current smoking in CD and ex-smoker status in UC) may refl ect a genotype sensitive to the infl ammatory eff ects of smoking. Phenotypic characterization among ethnic groups enhances the clinician ' s diagnostic and therapeutic approach to IBD in these populations, and allows for an appreciation of the role of IBD-specifi c genes in generating disease manifestations. Genotype -phenotype correlations are also likely to play a pivotal role in clinical practice as we enter the era of pharmacogenomics, enabling more targeted pharmacotherapy. Earlier initiation of biological agents or even a " top-down " approach may be warranted in the future depending on the presence of mutations associated with aggressive disease. Th us, characterization of IBD in ethnic groups has the potential to greatly benefi t patient care through ethnocentric management.
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Sacroiliitis, an EIM linked to the human leukocyte antigen (HLA) B27 antigen, was more common among French Canadians when the stricter ethnic defi nition was used.
A major strength of our study was the access to a wellcharacterized, large population of IBD patients across North America, which facilitated the detection of racial diff erences in the IBD phenotype with adjustment for confounders. Th e homogeneity in genetic background of the French-Canadian population was another advantage, allowing for a more dependable characterization of this condition.
Th e main limitation of our study was the potential for inherent referral bias, given that the majority of our patients were recruited at tertiary care centers. Th is may have aff ected the phenotypic characterization of IBD to some degree. On the other hand, however, the two populations that were being compared (French Canadian and Caucasian) were both tertiary-care referral populations, thus being of comparable severity. Th ere was also lack of information on medications used in the treatment of IBD. Th e point of initiation during the course of disease, and whether these agents were therapeutically eff ective, would have given us further insight into the severity of IBD in the studied population. Data on the level of education and socioeconomic status were not obtained either. Th ese may have repercussions on the access to appropriate treatment, and may play a role in the severity of disease or its complications.
In conclusion, our description of the IBD phenotype in French Canadians serves as a launching point for further exploration into the genotypic basis of this condition. Th e FrenchCanadian population with its founder eff ects off ered a unique opportunity for genotype -phenotype correlations. Th e result of particular interest was the signifi cantly decreased prevalence of 
